Cargando…

SARS-CoV-2 CD8(+) T cell killing assays using replicating viruses and transgenic antigens

The quality of an antigen-specific CD8(+) T cell repertoire is crucial for the clearance of intracellular pathogens, in particular for viral infections. Here, we describe killing assays to determine the function of CD8(+) T cells engineered with SARS-CoV-2-specific T cell receptors in a near-physiol...

Descripción completa

Detalles Bibliográficos
Autores principales: Mateyka, Laura M., Grass, Vincent, Pichlmair, Andreas, Busch, Dirk H., D’Ippolito, Elvira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411149/
https://www.ncbi.nlm.nih.gov/pubmed/36152303
http://dx.doi.org/10.1016/j.xpro.2022.101699
_version_ 1784775255216095232
author Mateyka, Laura M.
Grass, Vincent
Pichlmair, Andreas
Busch, Dirk H.
D’Ippolito, Elvira
author_facet Mateyka, Laura M.
Grass, Vincent
Pichlmair, Andreas
Busch, Dirk H.
D’Ippolito, Elvira
author_sort Mateyka, Laura M.
collection PubMed
description The quality of an antigen-specific CD8(+) T cell repertoire is crucial for the clearance of intracellular pathogens, in particular for viral infections. Here, we describe killing assays to determine the function of CD8(+) T cells engineered with SARS-CoV-2-specific T cell receptors in a near-physiological system for antigen presentation. We detail the use of target cells either infected with replicating SARS-CoV-2 virus or engineered with SARS-CoV-2 open reading frames. For complete details on the use and execution of this protocol, please refer to Moosmann et al. (2022) and Wagner et al. (2022).
format Online
Article
Text
id pubmed-9411149
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-94111492022-08-26 SARS-CoV-2 CD8(+) T cell killing assays using replicating viruses and transgenic antigens Mateyka, Laura M. Grass, Vincent Pichlmair, Andreas Busch, Dirk H. D’Ippolito, Elvira STAR Protoc Protocol The quality of an antigen-specific CD8(+) T cell repertoire is crucial for the clearance of intracellular pathogens, in particular for viral infections. Here, we describe killing assays to determine the function of CD8(+) T cells engineered with SARS-CoV-2-specific T cell receptors in a near-physiological system for antigen presentation. We detail the use of target cells either infected with replicating SARS-CoV-2 virus or engineered with SARS-CoV-2 open reading frames. For complete details on the use and execution of this protocol, please refer to Moosmann et al. (2022) and Wagner et al. (2022). Elsevier 2022-08-26 /pmc/articles/PMC9411149/ /pubmed/36152303 http://dx.doi.org/10.1016/j.xpro.2022.101699 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Protocol
Mateyka, Laura M.
Grass, Vincent
Pichlmair, Andreas
Busch, Dirk H.
D’Ippolito, Elvira
SARS-CoV-2 CD8(+) T cell killing assays using replicating viruses and transgenic antigens
title SARS-CoV-2 CD8(+) T cell killing assays using replicating viruses and transgenic antigens
title_full SARS-CoV-2 CD8(+) T cell killing assays using replicating viruses and transgenic antigens
title_fullStr SARS-CoV-2 CD8(+) T cell killing assays using replicating viruses and transgenic antigens
title_full_unstemmed SARS-CoV-2 CD8(+) T cell killing assays using replicating viruses and transgenic antigens
title_short SARS-CoV-2 CD8(+) T cell killing assays using replicating viruses and transgenic antigens
title_sort sars-cov-2 cd8(+) t cell killing assays using replicating viruses and transgenic antigens
topic Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411149/
https://www.ncbi.nlm.nih.gov/pubmed/36152303
http://dx.doi.org/10.1016/j.xpro.2022.101699
work_keys_str_mv AT mateykalauram sarscov2cd8tcellkillingassaysusingreplicatingvirusesandtransgenicantigens
AT grassvincent sarscov2cd8tcellkillingassaysusingreplicatingvirusesandtransgenicantigens
AT pichlmairandreas sarscov2cd8tcellkillingassaysusingreplicatingvirusesandtransgenicantigens
AT buschdirkh sarscov2cd8tcellkillingassaysusingreplicatingvirusesandtransgenicantigens
AT dippolitoelvira sarscov2cd8tcellkillingassaysusingreplicatingvirusesandtransgenicantigens